ReviewClinical and translational allergy2019
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.
Erratum issuedOpen access · goldAbstract readReview
In one paragraph
Review in Clinical and translational allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 49 papers.
0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 124 citations in OpenAlex.
- Association of Parental Health Literacy with Treatment Adherence and Clinical Outcomes in Adolescents with Allergic Rhinitis: A Controlled Longitudinal Study.Journal of clinical medicine · 2026Article
- Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.The World Allergy Organization journal · 2026Review
- ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.Clinical and translational allergy · 2026Article
- Article
- Thunderstorm-Associated Asthma in Shenzhen, China: A Retrospective Case-Control Study of Risk Factors, Clinical Characteristics, and Management Approaches.Journal of asthma and allergy · 2026Article
- Leveraging machine learning models to forecast pediatric allergic rhinitis exacerbation risk based on environmental exposure data.Frontiers in pediatrics · 2026Article
- Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report.Allergy · 2025Article
- Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025Article
- Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-airClinical and translational allergy · 2024Article
- Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.Clinical and translational allergy · 2024Article
- Action-plan and as-needed therapy in allergic rhinitis.Clinical and experimental pediatrics · 2024Article
- Proof-of-concept study of anti-Fel d 1 IgY antibodies in cat food using the MASK-airClinical and translational allergy · 2024Article
- Exploring the role of information and communication technologies in allergic rhinitis in specialist centers: Patient perspectives on usefulness, value, and impact on healthcare.Clinical and translational allergy · 2024Article
- iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control.Journal of asthma and allergy · 2024Article
- MiR-146a-5p engineered hucMSC-derived extracellular vesicles attenuateFrontiers in immunology · 2024Article
- Conception and pilot testing of a self-management health application for patients with pollen-related allergic rhinitis and allergic asthma-the APOLLO app.Scientific reports · 2023Article
- Vitamin D Role in Childhood Mite Allergy and Allergen Immunotherapy (AIT).Biomedicines · 2023Article
- Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders.JAMA network open · 2023Article
- Assessing the Feasibility of a Text-Based Conversational Agent for Asthma Support: Protocol for a Mixed Methods Observational Study.JMIR research protocols · 2023Article
- A retrospective study regarding the influence of COVID-19 disease on asthma.BMC pulmonary medicine · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
110 authors at 20 institutions in 27 countries.
J Bousquet1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.ORCID 0000-0001-9226-7762
A Bedbrook1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
W CzarlewskiMedical Consulting Czarlewski, Levallois, France.
G L Onorato1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
S ArnavielheKYomed INNOV, Montpellier, France.
D LauneKYomed INNOV, Montpellier, France.
E Mathieu-DupasKYomed INNOV, Montpellier, France.
J FonsecaCenter for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Medida, Lda Porto, Portugal.
E Costa8UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), Porto, Portugal.
O Lourenço9Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
M Morais-AlmeidaAllergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
A Todo-Bom11Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
M IllarioDivision for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
E Menditto13CIRFF, Federico II University, Naples, Italy.
G W Canonica14Personalized Medicine Clinic Asthma and Allergy, Humanitas Research Hospital, Humanitas University, Rozzano, Milan, Italy.
L CecchiSOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
R Monti16Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Turin, Italy.
L NapoliConsortium of Pharmacies and Services COSAFER, Salerno, Italy.
M T Ventura18Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
G De Feo19Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
W J FokkensDepartment of Otorhinolaryngology, Amsterdam University Medical Centre (AMC), Amsterdam, The Netherlands.
N H Chavannes21Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
S ReitsmaDepartment of Otorhinolaryngology, Amsterdam University Medical Centre (AMC), Amsterdam, The Netherlands.
A A Cruz22ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Vitória da Conquista, Brazil.
J da SilvaWHO GARD Planning Group, Salvador, Brazil.
F S Serpa24Department of Internal Medicine and Allergic Clinic of Professor Polydoro Ernani de Sao, Thiago University Hospital, Federal University of Santa Catarina (UFSC), Florianópolis, Brazil.
D Larenas-LinnemannCenter of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, Mexico City, Mexico.
J M Fuentes Perez27Hospital General Regional 1 "Dr Carlos Mc Gregor Sanchez Navarro" IMSS, Mexico City, Mexico.
Y R Huerta-Villalobos27Hospital General Regional 1 "Dr Carlos Mc Gregor Sanchez Navarro" IMSS, Mexico City, Mexico.
D Rivero-YeverinoAllergist, Mexico City, Mexico.
E Rodriguez-ZagalAllergist, Mexico City, Mexico.
A Valiulis29Clinic of Children's Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
R Dubakiene31Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
R Emuzyte32Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
V Kvedariene33Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
I Annesi-Maesano34Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Medical School Saint Antoine, Paris, France.
H Blain35Department of Geriatrics, Montpellier University Hospital, Montpellier, France.
P Bonniaud37CHU Dijon, Dijon, France.
I BosseAllergist, La Rochelle, France.
Y Dauvilliers39Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Montpellier, France.
P Devillier41UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
J F FontaineAllergist, Reims, France.
J L Pépin43Laboratoire HP2, Grenoble, INSERM, U1042, Université Grenoble Alpes, Grenoble, France.
N Pham-Thi45Allergy Department, Pasteur Institute, Paris, France.
F Portejoie1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
R PicardConseil Général de l'Economie Ministère de l'Economie, de l'Industrie et du Numérique, Paris, France.
N Roche47Pneumologie et Soins Intensifs Respiratoires, Hôpitaux Universitaires Paris, Centre Hôpital Cochin, Paris, France.
C RollandAssociation Asthme et Allergie, Paris, France.
P Schmidt-Grendelmeier49Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
P Kuna50Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
B Samolinski51Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
J M AntoISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
V Cardona56Allergy Section, Department of Internal Medicine, Hospital Vall 'dHebron & ARADyAL Research Network, Barcelona, Spain.
J Mullol57Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, University of Barcelona, Barcelona, Spain.
H Pinnock59Asthma UK Centre for Applied Research, The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
D Ryan60Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, Medical School, University of Edinburgh, Edinburgh, UK.
A Sheikh61The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
S Walker62Asthma UK, Mansell Street, London, UK.
S WilliamsInternational Primary Care Respiratory Group IPCRG, Aberdeen, Scotland, UK.
S Becker64Department of Otolaryngology, Head and Neck Surgery, University of Mainz, Mainz, Germany.
L KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
O Pfaar66Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Marburg, Germany.
K C Bergmann67Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R Mösges69Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany.
T Zuberbier67Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R E Roller-Wirnsberger71Department of Internal Medicine, Medical University of Graz, Graz, Austria.
P V Tomazic72Department of ENT, Medical University of Graz, Graz, Austria.
T Haahtela73Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
J SalimäkiAssociation of Finnish Pharmacies, Helsinki, Finland.
S Toppila-Salmi73Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
E Valovirta75Department of Lung Diseases and Clinical Immunology, Terveystalo Allergy Clinic, University of Turku, Turku, Finland.
T VasankariFILHA, Finnish Lung Association, Helsinki, Finland.
B Gemicioğlu77Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istambul, Turkey.
A Yorgancioglu78Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
N G Papadopoulos79Division of Infection, Immunity and Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
E P Prokopakis81Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece.
I G Tsiligianni61The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
S Bosnic-Anticevich83University of Sydney and Woolcock Emphysema Centre and Local Health District, Woolcock Institute of Medical Research, Glebe, NSW Australia.
R O'Hehir84Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
J C IvancevichServicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
H NeffenDirector of Center of Allergy, Immunology and Respiratory Diseases, Santa Fe, Argentina Center for Allergy and Immunology, Santa Fe, Argentina.
M E Zernotti88Universidad Católica de Córdoba, Córdoba, Argentina.
I Kull89Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
E Melén90Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
M Wickman91Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
C Bachert92Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium.
P W HellingsEuforea, Brussels, Belgium.
G Brusselle95Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
S Palkonen96EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
C Bindslev-JensenDepartment of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
E EllerDepartment of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
S Waserman98Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, ON Canada.
L P Boulet99Quebec Heart and Lung Institute, Laval University, Québec City, QC Canada.
J BouchardClinical Medecine, Laval's University, Quebec City, Canada.
D K ChuMedecine Department, Hôpital de la Malbaie, Quebec, Canada.
H J SchünemannMedecine Department, Hôpital de la Malbaie, Quebec, Canada.
M Sova102Department of Health Research Methods, Evidence and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, ON Canada.
G De Vries103Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
M van Eerd103Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
I Agache105Faculty of Medicine, Transylvania University, Brasov, Romania.
I J AnsoteguiDepartment of Allergy and Immunology, Hospital Quirón Bizkaia, Erandio, Spain.
M BewickiQ4U Consultants Ltd, London, UK.
T Casale108Division of Allergy/Immunology, University of South Florida, Tampa, USA.
M Dykewick109Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, MO USA.
M Ebisawa110Clinical Reserch Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
R MurrayMedical Communications Consultant, MedScript Ltd (Ireland & New Zealand), Dundalk, Ireland.
R Naclerio113Johns Hopkins School of Medicine, Baltimore, MD USA.
Y Okamoto114Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
D V Wallace115Nova Southeastern University, Fort Lauderdale, FL USA.
The MASK study group
Inserm · FRGhent University Hospital · BEUniversity of Helsinki · FIHôpital Arnaud de Villeneuve · FROdense University Hospital · DKAsthma UK · GBEuropean Union of Medical Specialists · BEHospital Clínic de Barcelona · ESHospital Médica Sur · MXHumanitas University · ITJohns Hopkins University · USLeiden University Medical Center · NLManisa Celal Bayar University · TRMedical University of Graz · ATMexican Social Security Institute · MXRegione Campania · ITTransylvania University of Brașov · ROUniversidad Católica de Córdoba · ARUniversidade do Porto · PTUniversidade Federal da Bahia · BR
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsMobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases.
methodsMASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS: Include patients, health care professionals (pharmacists and physicians), authorities, patient's associations, private and public sectors.
resultsMASK is deployed in 23 countries and 17 languages. 26,000 users have registered. EU GRANTS 2018: MASK is participating in EU projects (POLLAR: impact of air POLLution in Asthma and Rhinitis, EIT Health, DigitalHealthEurope, Euriphi and Vigour). LESSONS LEARNT: (i) Adherence to treatment is the major problem of allergic disease, (ii) Self-management strategies should be considerably expanded (behavioural), (iii) Change management is essential in allergic diseases, (iv) Education strategies should be reconsidered using a patient-centred approach and (v) Lessons learnt for allergic diseases can be expanded to chronic diseases.
Indexed as
AppAsthmaCare pathwaysDG SantéMASKmHealthRhinitis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.